Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 785-794

  Woollard, David J ^a   Gauci, Charles G ^a   Lightowlers, Marshall W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Echinococcus granulosus; EG95; Epitope; Synthetic peptide

Indexed keywords

ANTIGEN; ANTISERUM; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; DIPHTHERIA TOXOID; ECHINOCOCCOSIS; ECHINOCOCCUS; EPITOPE MAPPING; PEPTIDES; RECOMBINANT PROTEINS; SHEEP; SHEEP DISEASES;

EID: 0032745910     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00350-3     Document Type: Article

References (25)

1. Brown F.J. The potential of peptides as vaccines. Semin. Virology. 1:1990;67-74.
2. Adorini L., Harvey M.A., Miller A., Sercarz E.E. Fine specificity of regulatory T cells, II: suppressor and helper T cells are induced by different regions of hen eggwhite lysozyme in a genetically non-responder mouse strain. J. Exp. Med. 150:1979;293-306.
3. Robinson W.E.J., Kawamura T., Gorny M.K., Lake D., Xu J-Y., Matsumoto Y., Sugano T., Masuho Y., Mitchell W.M., Hersh E., Zolla-Pazner S. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro. Proc. Natl. Acad. Sci. USA. 87:1990;3185-3189.
4. Robinson J.H., Kehoe M.A. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol. Today. 13:1992;362-366.
5. Lightowlers M.W., Lawrence S.B., Gauci C.G., Young J., Ralston M., Maas D., Heath D.D. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol. 18:1996;457-462.
6. Heath D.D., Lawrence S.B. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules. Parasite Immunol. 18:1996;347-357.
7. Woollard D.J., Gauci C.G., Heath D.D., Lightowlers M.W. Epitope specificities and antibody responses to the EG95 hydatid vaccine. Parasite Immunol. 20:1998;535-540.
8. Valerio R.M., Bray A.M., Campbell R.A., DiPasquale A., Margellis C., Rodda S.J., Geysen H.M., Maeji N.J. Multipin peptide synthesis at the micromole scale using 2-hydroxyethyl methacrylate grafted polyethylene supports. Int. J. Pept. Protein Res. 42:1993;1-9.
9. Lee A.C.J., Powell J.E., Tregear G.W., Niall H.D., Stevens V.C. A method for preparing β-hCG COOH peptide-carrier conjugates of predictable composition. Mol. Immunol. 17:1980;749-756.
10. Smith D.B., Johnson K.S. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
11. Dadley-Moore D.L., Lightowlers M.W., Rothel J.S., Jackson D.C. Synthetic peptide antigens induce antibodies to Taenia ovis oncospheres. Vaccine. 17:1999;1506-1515.
12. Lightowlers M.W., Jensen O., Fernandez E., Iriarte J.A., Woollard D.J., Gauci C.G., Jenkins D.J., Heath D.D. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int. J. Parasitol. 29:1999;531-534.
13. Maina C.V., Riggs P.D., Grandea A.G.I., Slatko B.E., Moran L.S., Tagliamonte J.A., McReynolds L.A., Guan C. A vector to express and purify foreign proteins in Escherichia coli by fusion to, and separation from, maltose binding protein. Gene. 74:1988;365-373.
14. 2. Vet. Immunol. Immunopathol. 14:1987;187-196.
15. Bos E.S., van der Doelen A.A., van Rooy N., Schuurs A.H.W.M. 3,3′,5,5′-tetramethylbenzidine as an Ames-test negative chromogen for horse-radish peroxidase in enzyme immunoassay. J. Immunoassay. 2:1981;187-204.
16. Lise L.D., Mazier D., Jolivet M., Audibert F., Chedid L., Schlesinger D. Enhanced epitopic response to a synthetic human malarial peptide by pre-immunisation with tetanus toxoid carrier. Infect. Immun. 55:1987;2658-2661.
17. Beachey E.H., Tartar A., Seyer J.M., Chedid L. Epitope-specific protective immunogenicity of chemically synthesized 13-, 18- and 23-residue peptide fragments of streptococcal M protein. Proc. Natl. Acad. Sci. USA. 81:1984;2203-2207.
18. Good M.F., Maloy W.L., Lundee M.N., Morglait H., Cornette J.L., Smith G.L., Moss B., Miller L.M., Berzofsky J.A. Construction of a synthetic immunogen: use of a new T-helper epitope on malaria circumsporozoite antigen. Science. 235:1987;1059-1062.
19. Schulze-Gahmen U., Klenk H.D., Beyreuther K. Immunogenicity of loop-structured short synthetic peptides mimicking the antigenic site A of influenza virus hemagglutinin. Eur. J. Biochem. 159:1986;283-289.
20. Atassi M.Z. Preparation of monoclonal antibodies to pre-selected protein regions. Langone J.L., Van Vunakis H. Methods in enzymology. 1986;69 Academic Press, New York.
21. Jones G., Spencer L., Lord R., Mollard R., Pye D., Saul A. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity. Immunol. Lett. 24:1990;253-260.
22. Partidos C.D., Obeid O.E., Steward M.W. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides. Immunology. 77:1992;262-266.
23. Senpuku H., Iizima T., Yamaguchi Y., Nagata S., Ueno Y., Saito M., Hanada N., Nisizawa T. Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans. Immunology. 88:1996;275-283.
24. Kabat E.A. Heterogeneity and structure of antibody combining sites. Ann. NY Acad. Sci. 169:1970;43-54.
25. Schechter I. Mapping of the combining sites of antibodies specific to polyalanine chains. Ann. NY Acad. Sci. 190:1971;394-419.